Tenax Therapeutics Schedules Conference Call to Discuss Its Transformative Acquisition of PH Precision Med
A live webcast of the conference call and accompanying slides will be available under Events and Presentations in the Investors section of the Companys website at investors.tenaxthera.com .
- A live webcast of the conference call and accompanying slides will be available under Events and Presentations in the Investors section of the Companys website at investors.tenaxthera.com .
- The conference call can be accessed by dialing (877) 405-1242 from the U.S. and (201) 389-0852 internationally, followed by the conference ID: 13715313.
- An archived webinar recording of the event will be available on the website for approximately 30 days.
- Tenax Therapeutics, Inc., is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical need.